MinichMacGregor Wealth Management LLC Invests $297,000 in Axon Enterprise, Inc. (NASDAQ:AXON)

MinichMacGregor Wealth Management LLC purchased a new stake in Axon Enterprise, Inc. (NASDAQ:AXON) during the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 500 shares of the biotechnology company’s stock, valued at approximately $297,000.

Several other institutional investors also recently bought and sold shares of the company. Mutual Advisors LLC purchased a new stake in shares of Axon Enterprise during the fourth quarter worth $333,000. Magnus Financial Group LLC grew its stake in Axon Enterprise by 13.3% during the 4th quarter. Magnus Financial Group LLC now owns 2,584 shares of the biotechnology company’s stock valued at $1,536,000 after acquiring an additional 304 shares in the last quarter. Dakota Wealth Management raised its holdings in Axon Enterprise by 38.2% in the 4th quarter. Dakota Wealth Management now owns 4,634 shares of the biotechnology company’s stock valued at $2,754,000 after acquiring an additional 1,282 shares during the last quarter. Nisa Investment Advisors LLC lifted its stake in Axon Enterprise by 98.8% in the 4th quarter. Nisa Investment Advisors LLC now owns 7,521 shares of the biotechnology company’s stock worth $4,470,000 after purchasing an additional 3,737 shares in the last quarter. Finally, Atomi Financial Group Inc. boosted its holdings in shares of Axon Enterprise by 42.3% during the 4th quarter. Atomi Financial Group Inc. now owns 2,692 shares of the biotechnology company’s stock worth $1,600,000 after purchasing an additional 800 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Axon Enterprise

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the sale, the director now owns 6,929 shares of the company’s stock, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Jeffrey C. Kunins sold 21,834 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the completion of the transaction, the insider now owns 154,394 shares of the company’s stock, valued at $91,691,508.72. This represents a 12.39 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 50,545 shares of company stock valued at $30,721,337. 6.10% of the stock is currently owned by corporate insiders.

Axon Enterprise Price Performance

AXON opened at $607.60 on Thursday. The firm has a market cap of $46.33 billion, a price-to-earnings ratio of 157.00, a PEG ratio of 6.07 and a beta of 1.04. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The stock’s 50-day moving average price is $617.26 and its 200 day moving average price is $466.40. Axon Enterprise, Inc. has a 12-month low of $247.04 and a 12-month high of $698.67.

Analysts Set New Price Targets

AXON has been the topic of a number of analyst reports. Robert W. Baird lifted their price objective on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. TD Cowen initiated coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price objective for the company. Needham & Company LLC lifted their target price on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. Finally, JMP Securities increased their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research note on Thursday, October 31st. One analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat.com, Axon Enterprise has an average rating of “Moderate Buy” and an average target price of $504.92.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.